Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 278,286 |
|
|||||
| News | - | ||||||
| Day High | 3.07 | Low High |
|||||
| Day Low | 2.725 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lumos Pharma Inc | LUMO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.24 | 8.54% | 3.05 | 17:48:01 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.83 | 2.725 | 3.07 | 3.02 | 2.81 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,327 | 278,286 | US$ 2.99 | US$ 832,710 | - | 2.41 - 4.55 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:36:40 | formt | 4,142 | US$ 3.05 | USD |
Lumos Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.22M | 8.11M | - | 2.05M | -34.03M | -4.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lumos Pharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LUMO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.90 | 3.07 | 2.70 | 2.80 | 16,378 | 0.15 | 5.17% |
| 1 Month | 2.82 | 3.07 | 2.41 | 2.68 | 13,156 | 0.23 | 8.16% |
| 3 Months | 3.09 | 3.303 | 2.41 | 2.90 | 19,231 | -0.04 | -1.29% |
| 6 Months | 3.60 | 4.55 | 2.41 | 3.59 | 77,635 | -0.55 | -15.28% |
| 1 Year | 3.01 | 4.55 | 2.41 | 3.58 | 48,956 | 0.04 | 1.33% |
| 3 Years | 12.38 | 12.38 | 2.41 | 5.68 | 33,406 | -9.33 | -75.36% |
| 5 Years | 8.59 | 36.72 | 2.41 | 8.47 | 34,033 | -5.54 | -64.49% |
Lumos Pharma Description
| Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates primarily in the United States. |
